AQR Capital Management
BEAM icon

AQR Capital Management’s Beam Therapeutics BEAM Stock Holding History

AQR Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$374K Buy
15,692
+2,488
+19% +$69K ﹤0.01% 3292
2025
Q4 		$366K Buy
13,204
+1,978
+18% +$50.5K ﹤0.01% 3078
2025
Q3 		$272K Sell
11,226
-14,195
-56% -$282K ﹤0.01% 3128
2025
Q2 		$432K Buy
+25,421
New +$443K ﹤0.01% 2696
2024
Q4 		– Sell
-8,842
Closed -$217K – 2876
2024
Q3 		$217K Sell
8,842
-169
-2% -$4.37K ﹤0.01% 2528
2024
Q2 		$211K Buy
9,011
+2,487
+38% +$61.1K ﹤0.01% 2406
2024
Q1 		$216K Buy
+6,524
New +$203K ﹤0.01% 2237
2023
Q1 		– Sell
-9,599
Closed -$375K – 2166
2022
Q4 		$375K Sell
9,599
-42
-0.4% -$1.88K ﹤0.01% 1913
2022
Q3 		$459K Buy
+9,641
New +$550K ﹤0.01% 1820
2022
Q1 		– Sell
-7,424
Closed -$592K – 2218
2021
Q4 		$592K Sell
7,424
-15,304
-67% -$1.31M ﹤0.01% 1777
2021
Q3 		$1.98M Buy
22,728
+4,228
+23% +$425K ﹤0.01% 1155
2021
Q2 		$2.38M Buy
18,500
+7,979
+76% +$636K ﹤0.01% 1131
2021
Q1 		$842K Buy
10,521
+2,122
+25% +$202K ﹤0.01% 1626
2020
Q4 		$686K Buy
+8,399
New +$413K ﹤0.01% 1664

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AQR Capital Management's BEAM Position: Q1 2026 in Review

AQR Capital Management increased its Beam Therapeutics (BEAM) stake by 19% in Q1 2026, buying an estimated $69K and bringing the position to 15,692 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #3292.

AQR Capital Management first reported a position in BEAM in Q4 2020 and has held it in 14 quarters since. The position peaked at $2.38M in Q2 2021. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • AQR Capital Management held 15,692 shares of Beam Therapeutics worth $374K as of Q1 2026.
  • AQR Capital Management bought 2,488 Beam Therapeutics shares in Q1 2026, an estimated $69K.
  • Beam Therapeutics made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3292 holding.
  • AQR Capital Management first reported a position in Beam Therapeutics in Q4 2020 and has held it in 14 quarters since.
  • AQR Capital Management's Beam Therapeutics position peaked at $2.38M in Q2 2021.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.